167.91
0.67%
-1.13
Vorhandelsmarkt:
168.00
0.09
+0.05%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
Seeking Alpha
4 Oversold Stocks to Buy Right Now
The Motley Fool
Is Trending Stock Zoetis Inc. (ZTS) a Buy Now?
Zacks Investment Research
Zoetis (ZTS) Q1 2024 Earnings Call Transcript
The Motley Fool
Why Zoetis Stock Popped by Almost 6% on Thursday
The Motley Fool
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
Benzinga
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Zoetis (ZTS) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
3 Blue-Chip Bargains Trading At 52-Week Lows
Seeking Alpha
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Benzinga
1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation
The Motley Fool
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Zacks Investment Research
Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks Investment Research
Should You Invest in the VanEck Agribusiness ETF (MOO)?
Zacks Investment Research
Wall Street Analysts Look Bullish on Zoetis (ZTS): Should You Buy?
Zacks Investment Research
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
Zoetis Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Zacks Investment Research
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
Benzinga
Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks
Seeking Alpha
Zoetis (ZTS) Stock Moves -0.14%: What You Should Know
Zacks Investment Research
Company News for Apr 15, 2024
Zacks Investment Research
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
How's AT&T Handling Things?
The Motley Fool
Why Zoetis (ZTS) Dipped More Than Broader Market Today
Zacks Investment Research
Expert Outlook: Zoetis Through The Eyes Of 4 Analysts
Benzinga
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?
The Motley Fool
More Big Changes To My Dividend Growth Portfolio
Seeking Alpha
Zoetis (ZTS) Down 4.3% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
Nvidia is no longer Wall Street’s favorite stock. This company is.
MarketWatch
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
The Motley Fool
Should You Invest in the VanEck Agribusiness ETF (MOO)?
Zacks Investment Research
4 Analysts Have This To Say About Zoetis
Benzinga
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Zacks Investment Research
GRFS or ZTS: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Company News for Feb 14, 2024
Zacks Investment Research
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks Investment Research
Zoetis (ZTS) Q4 2023 Earnings Call Transcript
The Motley Fool
Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday?
Benzinga
Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins
Benzinga
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat
Zacks Investment Research
Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research
Zoetis (ZTS) Q4 Earnings Lag Estimates
Zacks Investment Research
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Zacks Investment Research
Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY
Zacks Investment Research
Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
Zacks Investment Research
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Zacks Investment Research
Ahead of Zoetis (ZTS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks Investment Research
Will Sage Therapeutics, Inc. (SAGE) Report Negative Earnings Next Week? What You Should Know
Zacks Investment Research
Kapitalisierung:
|
Volumen (24h):